Printer Friendly

FDA APPROVES U.S. CLINICAL EVALUATION OF NEW MEDTRONIC DEVICE FOR HEARTS THAT BEAT TOO FAST

 MINNEAPOLIS, Sept. 22 /PRNewswire/ -- Medtronic, Inc. (NYSE: MDT) announced today that the Food and Drug Administration had approved U.S. trials of the Medtronic Jewel(TM) PCD(R) arrhythmia management device, the world's smallest and most technologically advanced implantable defibrillator.
 The first U.S. implant of the Jewel took place today at the University of Minnesota Hospital and Clinic in Minneapolis where a pectoral implant was performed for a man who suffers from ventricular fibrillation secondary to coronary artery and valvular heart disease.
 The Jewel (Model 7219D) can be implanted in the pectoral position because it is 30 percent smaller than its predecessor, the Model 7217B PCD. The pectoral position significantly simplifies implantation. Implantable defibrillators currently released in the United States are typically implanted in the abdominal region because of their larger size.
 More that 200 patients have received the Jewel, which has been in clinical evaluations in Europe and Canada since March.
 In addition to its smaller size, the Jewel offers a biphasic pulse waveform, advanced detection capabilities, and stored electrograms intended to aid in diagnosis and the programming of optimal therapy for each patient. It is the first in Medtronic's Jewel system, a multi- product series of devices to treat rapid heartbeat.
 Medtronic, Inc., headquartered in Minneapolis, is the world's leading therapeutic medical device company.
 -0- 9/22/93
 /Note To Editors: Requests For Physician Interviews And Patient Information May Be Directed To Mary Stanik, University Of Minnesota, 612-624-4604./
 /CONTACT: Dale Beumer, investor relations, 612-574-3038; or Dick Reid, public relations, 612-574-3052; both of Medtronic/
 (MDT)


CO: Medtronic, Inc. ST: Minnesota IN: MTC SU:

KH-AL -- MN017 -- 4808 09/22/93 15:18 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 22, 1993
Words:274
Previous Article:FLEMING, FLORIDA SUPERMARKETS REACH SETTLEMENT AGREEMENT
Next Article:ADVANTAGEHEALTH ACQUIRES PHYSICAL THERAPY PRACTICE
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters